Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-004810
Filing Date
2023-01-09
Accepted
2023-01-09 16:48:37
Documents
5
Effectiveness Date
2023-01-09

Document Format Files

Seq Description Document Type Size
1 S-8 d395326ds8.htm S-8 64654
2 EX-5.1 d395326dex51.htm EX-5.1 8793
3 EX-23.1 d395326dex231.htm EX-23.1 1428
4 EX-FILING FEES d395326dexfilingfees.htm EX-FILING FEES 47708
5 GRAPHIC g395326g0109221408660.jpg GRAPHIC 2196
  Complete submission text file 0001193125-23-004810.txt   126975
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269167 | Film No.: 23518651
SIC: 3826 Laboratory Analytical Instruments